|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 340 out of 340 for Vav2

<< First    < Previous  |  Next >    Last >>
0.02s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
31570505 | J:302817
First Author: Huang R
Year: 2019
Journal: J Lipid Res
Title: The three members of the Vav family proteins form complexes that concur to foam cell formation and atherosclerosis.
Volume: 60
Issue: 12
Pages: 2006-2019
•
•
•
•
•
Publication
35154488 | J:320667
First Author: Tang C
Year: 2022
Journal: Theranostics
Title: Hedgehog signaling is controlled by Rac1 activity.
Volume: 12
Issue: 3
Pages: 1303-1320
•
•
•
•
•
Publication
17855053 | -
First Author: Lazer G
Year: 2007
Journal: Cell Signal
Title: The association of Sam68 with Vav1 contributes to tumorigenesis.
Volume: 19
Issue: 12
Pages: 2479-86
•
•
•
•
•
Protein Domain
IPR035879 | VAV1_SH2
Type: Domain
Description: This entry represents the SH2 domain of VAV1 from vertebrates.VAV1 (also known as proto-oncogene vav) is expressed predominantly in the hematopoietic system and it plays an important role in the development and activation of B and T cells [, , ]. It is activated by tyrosine phosphorylation to function as a guanine nucleotide exchange factor (GEF) for Rho GTPases following cell surface receptor activation, triggering various effects such as cytoskeletal reorganization, transcription regulation, cell cycle progression, and calcium mobilization [, ]. It also serves as a scaffold protein and has been shown to interact with Ku70, Socs1, Janus kinase 2, SIAH2, S100B, Abl gene, ZAP-70, SLP76, and Syk, among others []. The VAV protein family members are multiple domain proteins, including Vav from flies and VAV1/2/3 from mammals. VAV1 predominates in hematopoietic cells, whereas VAV2 and VAV3 are more broadly expressed. They have a calponin homology (CH) domain, an acidic domain (AC), a Dbl homology (DH) domain, a pleckstrin homology (PH) domain, a cysteine-rich (CR) domain containing a zinc finger, and a complex region with SH2 and SH3 domains. Therefore they may participate in the activity of several pathways [, ]. They are signal transducer proteins that couple tyrosine kinase signals with the activation of the Rho/Rac GTPases, [, , ].
•
•
•
•
•
Protein Domain
IPR035729 | VAV1_SH3_2
Type: Domain
Description: VAV1 (also known as proto-oncogene vav) is expressed predominantly in the hematopoietic system and it plays an important role in the development and activation of B and T cells [, , ]. It is activated by tyrosine phosphorylation to function as a guanine nucleotide exchange factor (GEF) for Rho GTPases following cell surface receptor activation, triggering various effects such as cytoskeletal reorganization, transcription regulation, cell cycle progression, and calcium mobilization [, ]. It also serves as a scaffold protein and has been shown to interact with Ku70, Socs1, Janus kinase 2, SIAH2, S100B, Abl gene, ZAP-70, SLP76, and Syk, among others []. The VAV protein family members are multiple domain proteins, including Vav from flies and VAV1/2/3 from mammals. VAV1 predominates in hematopoietic cells, whereas VAV2 and VAV3 are more broadly expressed. They have a calponin homology (CH) domain, an acidic domain (AC), a Dbl homology (DH) domain, a pleckstrin homology (PH) domain, a cysteine-rich (CR) domain containing a zinc finger, and a complex region with SH2 and SH3 domains. Therefore they may participate in the activity of several pathways [, ]. They are signal transducer proteins that couple tyrosine kinase signals with the activation of the Rho/Rac GTPases, [, , ]. This entry represents the second SH3 domain of VAV1. This domain interacts with a wide variety of proteins including cytoskeletal regulators (zyxin), RNA-binding proteins (Sam68), transcriptional regulators, viral proteins, and dynamin 2 [].
•
•
•
•
•
Protein Domain
IPR035730 | VAV1_SH3_1
Type: Domain
Description: VAV1 (also known as proto-oncogene vav) is expressed predominantly in the hematopoietic system and it plays an important role in the development and activation of B and T cells [, , ]. It is activated by tyrosine phosphorylation to function as a guanine nucleotide exchange factor (GEF) for Rho GTPases following cell surface receptor activation, triggering various effects such as cytoskeletal reorganization, transcription regulation, cell cycle progression, and calcium mobilization [, ]. It also serves as a scaffold protein and has been shown to interact with Ku70, Socs1, Janus kinase 2, SIAH2, S100B, Abl gene, ZAP-70, SLP76, and Syk, among others []. The VAV protein family members are multiple domain proteins, including Vav from flies and VAV1/2/3 from mammals. VAV1 predominates in hematopoietic cells, whereas VAV2 and VAV3 are more broadly expressed. They have a calponin homology (CH) domain, an acidic domain (AC), a Dbl homology (DH) domain, a pleckstrin homology (PH) domain, a cysteine-rich (CR) domain containing a zinc finger, and a complex region with SH2 and SH3 domains. Therefore they may participate in the activity of several pathways [, ]. They are signal transducer proteins that couple tyrosine kinase signals with the activation of the Rho/Rac GTPases, [, , ]. This entry represents the first SH3 domain of VAV1.
•
•
•
•
•
Publication
15767666 | J:97576
First Author: Brachmann SM
Year: 2005
Journal: Mol Cell Biol
Title: Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
Volume: 25
Issue: 7
Pages: 2593-606
•
•
•
•
•
Publication
10938113 | J:63932
First Author: Moores SL
Year: 2000
Journal: Mol Cell Biol
Title: Vav family proteins couple to diverse cell surface receptors.
Volume: 20
Issue: 17
Pages: 6364-73
•
•
•
•
•
Publication
23940720 | J:225189
First Author: Xu M
Year: 2013
Journal: PLoS One
Title: Contribution of NADPH oxidase to membrane CD38 internalization and activation in coronary arterial myocytes.
Volume: 8
Issue: 8
Pages: e71212
•
•
•
•
•
Publication
31300985 | J:295491
First Author: Mohammad G
Year: 2019
Journal: Mol Neurobiol
Title: Functional Regulation of an Oxidative Stress Mediator, Rac1, in Diabetic Retinopathy.
Volume: 56
Issue: 12
Pages: 8643-8655
•
•
•
•
•
Publication
12405184 | -
 
First Author: Turner M
Year: 2002
Journal: Adv Exp Med Biol
Title: The role of Vav proteins in B cell responses.
Volume: 512
Pages: 29-34
•
•
•
•
•
Publication
14592821 | -
First Author: Katzav S
Year: 2004
Journal: Blood
Title: Vav1: an oncogene that regulates specific transcriptional activation of T cells.
Volume: 103
Issue: 7
Pages: 2443-51
•
•
•
•
•
Publication
17590270 | -
First Author: Katzav S
Year: 2007
Journal: Cancer Lett
Title: Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies.
Volume: 255
Issue: 2
Pages: 241-54
•
•
•
•
•
Publication
12670394 | -
 
First Author: Tybulewicz VL
Year: 2003
Journal: Immunol Rev
Title: Vav1: a key signal transducer downstream of the TCR.
Volume: 192
Pages: 42-52
•
•
•
•
•
Publication
12165654 | -
First Author: Michel F
Year: 2002
Journal: Sci STKE
Title: CD28 costimulation: a source of Vav-1 for TCR signaling with the help of SLP-76?
Volume: 2002
Issue: 144
Pages: pe35
•
•
•
•
•
Publication
18511940 | -
First Author: Rapley J
Year: 2008
Journal: EMBO Rep
Title: Crucial structural role for the PH and C1 domains of the Vav1 exchange factor.
Volume: 9
Issue: 7
Pages: 655-61
•
•
•
•
•
Publication
20141838 | -
First Author: Yu B
Year: 2010
Journal: Cell
Title: Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1.
Volume: 140
Issue: 2
Pages: 246-56
•
•
•
•
•
Publication
26353933 | -
First Author: Katzav S
Year: 2015
Journal: Oncotarget
Title: Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.
Volume: 6
Issue: 30
Pages: 28731-42
•
•
•
•
•
Publication
10669724 | -
First Author: Bustelo XR
Year: 2000
Journal: Mol Cell Biol
Title: Regulatory and signaling properties of the Vav family.
Volume: 20
Issue: 5
Pages: 1461-77
•
•
•
•
•
Protein Domain
IPR037832 | PH_Vav
Type: Domain
Description: Vav acts as a guanosine nucleotide exchange factor (GEF) for Rho/Rac proteins. They control processes including T cell activation, phagocytosis, and migration of cells. The Vav subgroup of Dbl GEFs consists of three family members (Vav1, Vav2, and Vav3) in mammals []. Vav1 is preferentially expressed in the hematopoietic system, while Vav2 and Vav3 are described by broader expression patterns []. Mammalian Vav proteins consist of a calponin homology (CH) domain, an acidic region, a catalytic Dbl homology (DH) domain, a PH domain, a zinc finger cysteine rich domain (C1/CRD), and an SH2 domain, flanked by two SH3 domains. In invertebrates such as Drosophila and C. elegans, Vav is missing the N-terminal SH3 domain. The DH domain is involved in RhoGTPase recognition and selectivity and stimulates the reorganization of the switch regions for GDP/GTP exchange []. The PH domain is implicated in directing membrane localization, allosteric regulation of guanine nucleotide exchange activity, and as a phospholipid-dependent regulator of GEF activity []. Vavs bind RhoGTPases including Rac1, RhoA, and RhoG, while other members of the GEF family are specific for a single RhoGTPase. This promiscuity is thought to be a result of its CRD [].PH domains have diverse functions, but in general are involved in targeting proteins to the appropriate cellular location or in the interaction with a binding partner []. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. Less than 10% of PH domains bind phosphoinositide phosphates (PIPs) with high affinity and specificity[]. PH domains are distinguished from other PIP-binding domains by their specific high-affinity binding to PIPs with two vicinal phosphate groups: PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3 which results in targeting some PH domain proteins to the plasma membrane []. A few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes [].
•
•
•
•
•
Protein
P27870
Organism: Mus musculus/domesticus
Length: 845  
Fragment?: false
•
•
•
•
•
Protein
Q3UAH3
Organism: Mus musculus/domesticus
Length: 845  
Fragment?: false
•
•
•
•
•
Protein
Q3UAV5
Organism: Mus musculus/domesticus
Length: 821  
Fragment?: false
•
•
•
•
•
Protein
Q3U8U1
Organism: Mus musculus/domesticus
Length: 845  
Fragment?: false
•
•
•
•
•
Protein
Q3U4K7
Organism: Mus musculus/domesticus
Length: 845  
Fragment?: false
•
•
•
•
•
Protein
Q3TXC4
Organism: Mus musculus/domesticus
Length: 845  
Fragment?: false
•
•
•
•
•
Protein
Q3UAG9
Organism: Mus musculus/domesticus
Length: 845  
Fragment?: false
•
•
•
•
•
Protein
E9PXI0
Organism: Mus musculus/domesticus
Length: 821  
Fragment?: false
•
•
•
•
•
Protein
Q3U9E2
Organism: Mus musculus/domesticus
Length: 845  
Fragment?: false
•
•
•
•
•
Protein
Q3U670
Organism: Mus musculus/domesticus
Length: 845  
Fragment?: false
•
•
•
•
•
Protein
Q8VDU4
Organism: Mus musculus/domesticus
Length: 806  
Fragment?: false
•
•
•
•
•
Protein
O08526
Organism: Mus musculus/domesticus
Length: 166  
Fragment?: false
•
•
•
•
•
Protein
Q3V0U7
Organism: Mus musculus/domesticus
Length: 146  
Fragment?: true
•
•
•
•
•
Protein
Q9R0C8
Organism: Mus musculus/domesticus
Length: 847  
Fragment?: false
•
•
•
•
•
Publication
15493994 | -
First Author: Lemmon MA
Year: 2004
Journal: Biochem Soc Trans
Title: Pleckstrin homology domains: not just for phosphoinositides.
Volume: 32
Issue: Pt 5
Pages: 707-11
•
•
•
•
•
Publication
14594214 | -
 
First Author: Cozier GE
Year: 2004
Journal: Curr Top Microbiol Immunol
Title: Membrane targeting by pleckstrin homology domains.
Volume: 282
Pages: 49-88
•
•
•
•
•
Publication
22728242 | -
First Author: Scheffzek K
Year: 2012
Journal: FEBS Lett
Title: Pleckstrin homology (PH) like domains - versatile modules in protein-protein interaction platforms.
Volume: 586
Issue: 17
Pages: 2662-73
•
•
•
•
•
Publication
15489334 | -
First Author: Gerhard DS
Year: 2004
Journal: Genome Res
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Volume: 14
Issue: 10B
Pages: 2121-7
•
•
•
•
•
Publication
21183079 | J:292518
First Author: Huttlin EL
Year: 2010
Journal: Cell
Title: A tissue-specific atlas of mouse protein phosphorylation and expression.
Volume: 143
Issue: 7
Pages: 1174-89
•
•
•
•
•
Publication
19468303 | -
First Author: Church DM
Year: 2009
Journal: PLoS Biol
Title: Lineage-specific biology revealed by a finished genome assembly of the mouse.
Volume: 7
Issue: 5
Pages: e1000112
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom